Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Location

MS status

Recruitment Status

Phase

Drugs

Prior Immunotherapy Allowed

NCT ID

Title key word search

Date Trial Added

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Phase	Date Added	Location	Prior IO Allowed	CRC-directed	Status	Drugs	Tags
NCT ID NCT03290937	TitleUtomilumab, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Metastatic Colorectal Cancer	Phase Phase 1	Date Added 2017-09-25	Location Texas, United States	Prior IO Allowed No	CRC-directed Yes	Status Active, not recruiting	Drugs cetuximab, Irinotecan Hydrochloride, Utomilumab	Tags MSS/ MMRp
NCT ID NCT04535024	TitleThe Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in MSS Oligometastatic Colorectal Cancer	Phase Phase 2	Date Added 2020-09-01	Location China	Prior IO Allowed No	CRC-directed Yes	Status Recruiting	Drugs Sintilimab	Tags MSS/ MMRp
NCT ID NCT05292417	TitleRadiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRC	Phase Phase 2	Date Added 2022-03-23	Location China	Prior IO Allowed No	CRC-directed Yes	Status Recruiting	Drugs Fruquintinib, GM-CSF, Sintilimab	Tags MSS/ MMRp
NCT ID NCT04687631	TitleConversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases	Phase Phase 3	Date Added 2020-12-29	Location China	Prior IO Allowed No	CRC-directed Yes	Status Recruiting	Drugs mFOLFOXIRI Plus Bevacizumab, mFOLFOXIRI plus Cetuximab	Tags MSI-H/ MMRd, MSS/ MMRp
NCT ID LUMINESCENCE	TitleIpilimumab, Maraviroc and Nivolumab (LUMINESCENCE)	Phase Phase 1	Date Added 2019-01-25	Location	Prior IO Allowed No	CRC-directed Yes	Status Recruiting	Drugs Ipilimumab, maraviroc, Nivolumab, Celsentri, Opdivo, Selzentry, Yervoy	Tags MSS/ MMRp
NCT ID NCT04866862	TitleFruquitinib Combined With Camrelizumab in Non MSI-H/dMMR Refractory Colorectal Cancer	Phase Phase 2	Date Added 2021-04-30	Location China	Prior IO Allowed No	CRC-directed Yes	Status Recruiting	Drugs Combination of Fruquintinib and Camrelizumab	Tags MSS/ MMRp
NCT ID NCT03835949	TitleStudy of TJ004309 in Combination With Atezolizumab (Tecentriq(R)) in Patients With Advanced or Metastatic Cancer	Phase Phase 1	Date Added 2019-02-11	Location Alabama, United States Arizona, United States California, United States Texas, United States	Prior IO Allowed No	CRC-directed No	Status Active, not recruiting	Drugs Atezolizumab, TJ004309	Tags MSS/ MMRp
NCT ID NCT04432857	TitleAN0025 and Pembrolizumab Combination in Advanced Solid Tumors	Phase Phase 1	Date Added 2020-06-16	Location Missouri, United States Texas, United States Utah, United States Virginia, United States France	Prior IO Allowed No	CRC-directed Yes	Status Active, not recruiting	Drugs AN0025, Pembrolizumab	Tags MSS/ MMRp
NCT ID NCT03239145	TitlePembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor	Phase Phase 1	Date Added 2017-08-03	Location Massachusetts, United States	Prior IO Allowed No	CRC-directed Yes	Status Completed	Drugs Pembrolizumab, Trebananib	Tags MSS/ MMRp
NCT ID NCT03494946	TitleLiver Transplantation Compared to Chemotherapy in Patients With ColoRectal Cancer	Phase Not Applicable	Date Added 2018-04-11	Location Norway	Prior IO Allowed No	CRC-directed Yes	Status Recruiting	Drugs Chemotherapy	Tags MSI-H/ MMRd, MSS/ MMRp

Showing 211 to 220 of 299 entries